竹内 啓善

Medicine & Life Sciences

1. Schizophrenia 100%
2. Antipsychotic Agents 87%
3. Clozapine 29%
4. Systematic Reviews 27%
5. Meta-Analysis 20%
6. Risperidone 19%
7. Olanzapine 18%
8. Dopamine D2 Receptors 17%
9. Cognition 11%
10. Polypharmacy 11%
11. Clinical Trials 10%
12. Aripiprazole 10%
13. Brief Psychiatric Rating Scale 9%
14. Cognitive Dysfunction 9%
15. Randomized Controlled Trials 9%
16. Psychotic Disorders 8%
17. Therapeutics 8%
18. Maintenance 8%
19. Antidepressive Agents 8%
20. Depression 8%
21. Psychiatry 6%
22. Quetiapine Fumarate 6%
23. Japan 5%
24. Recurrence 5%
25. Pharmacology 5%
26. Major Depressive Disorder 5%